Home » Topics » BioWorld Science

BioWorld Science
RSS

AMP-CpG-adjuvanted vaccine confers potent immunity against SARS-CoV-2 infection

Sep. 23, 2021

Oncolytic viruses target GSCs with specific p53 deregulations for personalized glioblastoma therapy

Sep. 23, 2021

Inhaled antibodies brought to SARS-CoV fight

Sep. 22, 2021

Synthetic queuine STL-101 shows neuroprotective potential

Sep. 22, 2021

Mosaic licenses rights to novel vaccine candidates from UC San Diego

Sep. 22, 2021

Novel OSBPL7-targeting compounds show therapeutic efficacy in models of renal disease

Sep. 22, 2021

SNP in the CBS gene tied to overall survival in patients with NSCLC

Sep. 22, 2021

Theragnostics and AAA to jointly develop Ga-68 one-step PET radiopharmaceuticals

Sep. 22, 2021

CMTA and Addex collaborate to investigate GABA-B PAMs for CMT1A

Sep. 22, 2021

Clearmind and Hebrew University partner on novel psychedelics

Sep. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...